Effect of Admission Diabetes History on Safety and Efficacy of Early Tirofiban Infusion after Intravenous Thrombolysis in Ischaemic Stroke: a post-hoc analysis
This study aimed to investigate how diabetes mellitus (DM) influences the efficacy of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic noncardioembolic stroke. This was a post-hoc analysis of the ASSET-IT (Advancing Stroke Safety and
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.